Price Chart

Profile

Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.
URL https://www.harpoontx.com
Investor Relations URL https://ir.harpoontx.com/
HQ State/Province California
Sector  
Industry  
Equity Style Small Cap/Blend
Next Earnings Release May. 31, 2024 (est.)
Last Earnings Release Nov. 09, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.
URL https://www.harpoontx.com
Investor Relations URL https://ir.harpoontx.com/
HQ State/Province California
Sector  
Industry  
Equity Style Small Cap/Blend
Next Earnings Release May. 31, 2024 (est.)
Last Earnings Release Nov. 09, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A